First Trimester Pregnancy Clinical Trial
Official title:
Sublingual Versus Vaginal Misoprostol for Cervical Dilatation 1 or 3 Hours Prior to Surgical Abortion
Despite of the widespread use, and extensive studies, the optimal route of administration of misoprostol before surgical abortion remains to be defined. Following administration of 400 mcg vaginally as per clinical guidelines, the time for optimal priming seems to be 3 hours, but the longer the interval the greater the risk or bleeding and expulsion of the uterine contents before the surgical evacuation. Sublingual administration seems to give adequate plasma concentration and cervical priming faster than oral or vaginal administration. This may allow a shorter waiting time with maintained efficacy, less side effects and logistic advantages.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT01988740 -
Markers of Oxidative Stress in a Early Week Miscarriage: Ischemia of Modified Albumin
|
N/A | |
| Terminated |
NCT01011634 -
Trial Comparing Intravenous and Oral Moderate Sedation for First Trimester Surgical Abortions
|
Phase 4 | |
| Active, not recruiting |
NCT04707456 -
Comparative Study of Learning Curve for First Trimester Fetal Anomaly Scan
|
N/A |